FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to the pharmaceutical industry and is a composition containing medium chain triglyceride (TC), having structural formula (1), where each R', R'' and R''' esterified with a glycerol chain is an independent fatty acid with 5-12 carbon atoms, for use in combination with an anti-epileptic agent (AED) to enhance the AED effect in an animal, composition contains 1 wt. % to 15 wt. % TCS and wherein composition also contains 15 to 50 % protein, 5 wt. % to 40 wt. % fat, 5 wt. % to 10 wt. % ash and has a moisture content from 5 wt. % to 20 wt. %.
EFFECT: invention provides higher therapeutic effectiveness of the administered antiepileptic agent (AED).
6 cl, 1 ex, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS AND METHODS FOR INTENSIFYING NEUROGENESIS IN ANIMALS | 2016 |
|
RU2735834C2 |
| NUTRITIONAL COMPOSITIONS FOR HEART PROTECTION IN COMPANION ANIMALS | 2017 |
|
RU2744134C2 |
| COMPOSITION FOR USE IN THE TREATMENT OF EPILEPSY | 2018 |
|
RU2793246C2 |
| ESLICARBAZEPINE ACETATE AND METHODS FOR APPLYING THEREOF | 2005 |
|
RU2417085C2 |
| COMPOSITION AND METHOD OF APPLICATION IN CARTILAGE INVOLVEMENTS | 2006 |
|
RU2380109C2 |
| SUBSTITUTED TRIA-AZOLES AND METHODS RELATING THERETO | 2016 |
|
RU2718049C2 |
| COMPOSITIONS AND METHODS FOR MODIFICATION OF GASTRO-INTESTINAL FLORA | 2011 |
|
RU2585851C2 |
| METHOD OF REDUCING WEIGHT BY ADMINISTERING MCT TO PROVIDE HEALTH EFFECTS IN ANIMALS | 2020 |
|
RU2826080C2 |
| COMBINATION CONTAINING DECANOIC ACID FOR TREATMENT OF EPILEPSY | 2018 |
|
RU2779202C2 |
| METHODS FOR IMPROVING XENOBIOTIC DEACTIVATION BY LIVER IN ANIMALS | 2005 |
|
RU2432159C2 |
